DNA vaccine encoding avian influenza virus H5 and Esat-6 of Mycobacterium tuberculosis improved antibody responses against AIV in chickens

Comparative Immunology, Microbiology and Infectious Diseases

Volumn 33, Issue 6, 2010, Pages 491-503

  Oveissi, Sara ^a   Omar, Abdul Rahman ^a   Yusoff, Khatijah ^a   Jahanshiri, Fatemeh ^a   Hassan, Sharifah Syed ^b  

^a UNIVERSITY PUTRA MALAYSIA   (Malaysia)

^b MONASH UNIVERSITY MALAYSIA   (Malaysia)

Author keywords

Avian influenza virus; DNA vaccine; ELISA; Esat 6 gene; Genetic adjuvant; H5 gene; HI antibody titer; Mycobacterium tuberculosis

Indexed keywords

ANTIBODY; DNA VACCINE; EARLY SECRETORY ANTIGENIC TARGET 6; PLASMID DNA; PROTEIN H5; UNCLASSIFIED DRUG; VIRUS PROTEIN;

ANIMAL CELL; ANIMAL EXPERIMENT; ANTIBODY DETECTION; ANTIBODY RESPONSE; ANTIBODY TITER; ARTICLE; AVIAN INFLUENZA; CHICKEN; CONTROLLED STUDY; ENZYME LINKED IMMUNOSORBENT ASSAY; GENETIC TRANSFECTION; H5 GENE; HEMAGGLUTINATION INHIBITION TEST; INFLUENZA VACCINATION; INFLUENZA VIRUS A H5N1; MOLECULAR CLONING; NONHUMAN; VERO CELL; VIRUS GENE;

ADJUVANTS, IMMUNOLOGIC; ANIMALS; ANTIBODIES, VIRAL; ANTIGENS, BACTERIAL; BACTERIAL PROTEINS; BLOTTING, WESTERN; CHICKENS; ENZYME-LINKED IMMUNOSORBENT ASSAY; FLUORESCENT ANTIBODY TECHNIQUE, INDIRECT; HEMAGGLUTINATION INHIBITION TESTS; HEMAGGLUTININ GLYCOPROTEINS, INFLUENZA VIRUS; INFLUENZA A VIRUS, H5N1 SUBTYPE; INFLUENZA IN BIRDS; INFLUENZA VACCINES; REVERSE TRANSCRIPTASE POLYMERASE CHAIN REACTION; VACCINES, DNA;

AVIAN INFLUENZA VIRUS; GALLUS GALLUS; MYCOBACTERIUM TUBERCULOSIS;

EID: 78650203349     PISSN: 01479571     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.cimid.2009.08.004     Document Type: Article

References (30)

1. Alexander D.J. A review of avian influenza in different bird species. Vet Microbiol 2000, 74:3-13.
2. Scarselli M., Giuliani M.M., Adu-Bobie J., Pizza M., Rappuoli R. The impact of genomics on vaccine design. Trends Biotechnol 2005, 23:84-91.
3. Wack A., Rappuoli R. Vaccinology at the beginning of the 21st century. Curr Opin Immunol 2005, 17:411-418.
4. O'Hagan D.T., Valiante N.M. Recent advances in the discovery and delivery of vaccine adjuvants. Nat Rev 2003, 2:727-735.
5. Liu M.A., Ulmer J.B. Human clinical trials of plasmid DNA vaccines. Adv Genet 2005, 55:25-40.
6. Arulkanthan A., Brown W.C., McGuire T.C., Knowles D.P. Biased immunoglobulin G1 isotype responses induced in cattle with DNA expressing mspla of Anaplasma marginale. Infect Immun 1999, 67:3481-3487.
7. Wang R., Epstein J., Baraceros F.M., Gorak E.J., Charoenvit Y., Carucci D.J., et al. Induction of CD4+ T cell-dependent CD8+ type 1 responses in humans by a malaria DNA vaccine. PNAS (USA) 2001, 98:10817-10822.
8. Cavazzana-Calvo M., Hacein-Bey-Abina S., de Saint Basile G., Gross F., Yvon E., Nusbaum P., et al. Gene therapy of human severe combined immunodeficiency (SCID)-X1 disease. Science 2002, 288:669-672.
9. Scheerlinck J.P.Y. Genetic adjuvants for DNA vaccines. Vaccines 2001, 19:2647-2656.
10. Nicholson K.G., Wood J.M., Zambon M. Influenza. Lancet 2003, 362:1733-1744.
11. Brodin P., Rosenkrand I., Andersen P., Cole S.T., Brosch R. ESAT-6 proteins: protective antigens and virulence factors?. Trend Microbiol 2004, 12:500-508.
12. Majlessi L., Brodin P., Brosch R., Rojas M.J., Khun H., Huerre M., et al. Influence of ESAT-6 secretion system 1 (RD1) of Mycobacterium tuberculosis on the interaction between mycobacteria and the host immune system. J Immunol 2005, 174:3570-3579.
13. Lopez-Vidal Y., Leon-Rosales S.P., Castanon-Arreola M., Rangel-Frausto M.S., Melendez-Herrada E., Sada-Diaz E. Response of IFN-gamma and IgG to ESAT-6 and 38kDa recombinant proteins and their peptides from Mycobacterium tuberculosis patients and asymptomatic household contacts may induce possible early-stage infection in the latter. Arch Med Res 2004, 35:308-317.
14. Brusasca P.N., Peters R.L., Motzel S.L., Klien H.J., Gennaro M.L. Antigen recognition by serum antibodies in non-human primates experimentally infected with Mycobacterium tuberculosis. Comp Med 2003, 53:165-172.
15. Pollock J.M., Andersen P. The potential of the ESAT-6 antigen secreted by virulent mycobacteria for specific diagnosis of tuberculosis. J Infect Dis 1997, 175:1251-1254.
16. Sambrook J., Fritsch E.F., Maniatis T. Molecular Cloning: A Laboratory Manual 1989, vol. 1. Cold-Spring Harbor, New York, pp. 1.74-1.84. 2nd ed.
17. Vogel J., Shelokov A. Absorption-haemagglutination test for influenza virus in monkey kidney tissue culture. Science 1957, 126:358-359.
18. Fynan E.F., Webster R.G., Fuller D.H., Haynes J.R., Santoro J.C., Robinson H.L. DNA vaccines: protective immunizations by parenteral, mucosal, and gene-gun inoculations. PNAS (USA) 1993, 90:11478-11482.
19. Kodihalli S., Kobasa D.L., Webster R.G. Strategies for inducing protection against avian influenza A virus subtypes with DNA vaccines. Vaccine 2000, 18:2592-2599.
20. Epstein S.L., Tumpey T.M., Misplon J.A., Lo C.Y., Cooper L.A., Subbarao K., et al. DNA vaccine expressing conserved influenza virus proteins protective against H5N1 challenge infection in mice. Emerg Inf Dis 2002, 8:796-801.
21. Liu M.A., McClements W., Ulmer J.B., Shiver J., Donnelly J. Immunization of non-human primates with DNA vaccines. Vaccine 1997, 15:909-912.
22. Jiang Y., Yu K., Zhang H., Zhang P., Li C., Tian G., et al. Enhanced protective efficacy of H5 subtype avian influenza DNA vaccine with codon optimized HA gene in a pCAGGS plasmid vector. Antiviral Res 2007, 75:234-241.
23. Krieg A.M., Yi A.K., Schorr J., Davis H.L. The role of CpG dinucleotides in DNA vaccines. Trends Microbiol 1998, 6:23-27.
24. Mahmood M.S., Siddique M., Hussain I., Khan A., Mansoor M.K. Protection capability of recombinant plasmid DNA vaccine containing VP2 gene of very virulent infectious bursal disease virus in chickens adjuvanted with CpG oligodeoxynucleotide. Vaccine 2006, 24:4838-4846.
25. Liu S., Shi L., Cheng Y.B., Fan G.X., Ren H.X., Yuan Y.K. Evaluation of protective effect of multi-epitope DNA vaccine encoding six antigen segments of Toxoplasma gondii in mice. Parasitol Res 2009, 105:267-274.
26. Dalloul R.A., Lillehoj H.S., Okamura M., Xie H., Min W., Ding X., et al. In vivo effects of CpG oligodeoxynucleotide on Eimeria infection in chickens. Avian Dis 2004, 48:783-790.
27. Kodihalli S., Haynes J.R., Robinson H., Webster R.G. Cross protection among lethal H5N2 influenza viruses induced by DNA vaccine to the hemagglutinin. J Virol 1997, 71:3391-3396.
28. Zheng F.R., Sun X.Q., Liu H.Z., Zhang J.X. Study on the distribution and expression of a DNA vaccine against lymphocystis disease virus in Japanese flounder (Paralichthys olivaceus). Aquaculture 2006, 261:1128-1134.
29. Wolff J.A., Ludtke J.J., Acsadi G., Williams P., Jani A. Long-term persistence of plasmid DNA and foreign gene expression in mouse muscle. Hum Mol Genet 1992, 1:363-369.
30. Lee C.W., Senne D.A., Suarez D.L. Development and application of reference antisera against 15 hemagglutinin subtypes of influenza virus by DNA vaccination of chickens. Clin Vaccine Immunol 2006, 13:395-402.